A digital health platform for assisting the diagnosis and monitoring of COVID-19 progression: An adjuvant approach for augmenting the antiviral response and mitigating the immune-mediated target organ damage
Under a Creative Commons license
open access
Abbreviations
COVID-19
coronavirus disease 2019
CoV
coronavirus
ARDS
acute respiratory distress syndrome
SARS
severe acute respiratory syndrome
MERS
Middle East respiratory syndrome
RT-PCR
reverse transcriptase polymerase chain reaction
IFNβ
interferon-beta
RNA
ribonucleic acid
dsRNA
double-stranded RNA
TLR
toll-like receptors
RIG-I
retinoic acid-inducible gene I
NF-κB
nuclear factor kappa-light-chain
IRF
interferon regulatory factor
IFN
interferon
JAK-STAT
Janus kinase signal transducer and activation of transcription
IFNR
type I IFN receptor
PRM
patterns recognition molecules
IL
interleukin
NK cells
natural killer cells
Th cells
T helper cells
APC
antigen-presenting cells
CTL
cytotoxic T cells
ICU
intensive care unit
IP-10
IFN gamma-induced protein 10
MCP
monocyte chemoattractant protein
TNF
tumor necrosis factor
NLR
neutrophil-lymphocyte ratio
Tregs
regulatory T cells
CD
cluster of differentiation
NKT
NK T cells
HLH
hemophagocytic lymphohistiocytosis
S-1P
sphingosine-1-phosphate
GC
glucosylceramide
HCC
hepatocellular carcinoma
SphK
sphingosine kinase
MT
microtubules
HBC
hyperimmune bovine colostrum
IG
immunoglobulin
HRV
heart rate variability
SK1
sphingokinase 1
Keywords
COVID-19
Coronavirus
Digital health
Antiviral therapy
Antiviral response
ARDS
Cited by (0)
© 2021 The Author(s). Published by Elsevier Masson SAS.